Outcomes of Japanese patients with non-alcoholic fatty liver disease according to genetic background and lifestyle-related diseases

• Main Authors: Tomomi Kogiso, Takaomi Sagawa, Kazuhisa Kodama, Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige
• Format: Article
• Language: English
• Published: Elsevier 2021-03-01
• Series: Annals of Hepatology
• Subjects: Non-alcoholic fatty liver disease (NAFLD); Mortality; Single nucleotide polymorphism (SNP); Patatin-like phospholipase 3 (PNPLA3); Aldehyde dehydrogenase 2 (ALDH2)
• Online Access: http://www.sciencedirect.com/science/article/pii/S1665268120301757

Introduction and objectives: Genetic background may be involved in the mechanisms of liver injury and the development of non-alcoholic fatty liver disease (NAFLD). However, its contributions to the long-term outcome of NAFLD have been unclear. Methods: We enrolled 314 Japanese patients with biopsy-confirmed NAFLD from 2000 to 2018 (161 men [51.3%]; median age, 53 [14–84] years; 114 with advanced fibrosis [37.5%]) in the patients without hepatocellular carcinoma at diagnosis. Genomic DNA was extracted from peripheral blood and single nucleotide polymorphisms (SNPs) were analyzed. Associations of mortality with patatin-like phospholipase 3 (PNPLA3) and aldehyde dehydrogenase 2 (ALDH2) were analyzed. Finally, a subgroup analysis according to lifestyle-related disease was performed. Results: During the median 7 years of follow-up, 20 patients (6.4%) died (13 liver-related [4.1%] and 7 non-liver-related deaths [2.2%]). Patients with ALDH2 (non-GG genotype) who had reduced alcohol metabolism tended to have a poor prognosis (p = 0.06). Patients carrying both risk SNPs of PNPLA3 (GG) and ALDH2 (non-GG) had a significantly poor prognosis (p = 0.01). In the subgroup analysis, patients with PNPLA3 (GG) who were non-diabetics (p = 0.06) or non-dyslipidemic (p = 0.03), with ALDH2 (non-GG) who were non-dyslipidemic (p = 0.01) or hypertensive (p = 0.03), also had a poor prognosis. The Cox analysis revealed that ALDH2 (non-GG) was associated with a poor prognosis (Hazard ratio: 4.568, 95% Confidence Interval: 1.294–16.131, p = 0.02) similar to the liver function tests. Conclusions: Genetic background may affect NAFLD prognosis and ALDH2 SNP could predict the outcome.